VMCP-VBAP Regimen

Known as: Vincristine-Melphalan-Cytoxan-Prednisone (VMCP)/Vincristine-BCNU-Adriamycin-Prednisone (VBAP) Regimen 
A regimen consisting of vincristine, melphalan, cyclophosphamide and prednisone (VMCP) alternating with vincristine, carmustine (BCNU), doxorubicin… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2005
0119862005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Survival of patients with multiple myeloma (MM) showed no improvement between the 1960s and 1990s. During the last decade, new… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
Review
1999
Review
1999
Nonsecretory myeloma, which accounts for 1% to 5% of all myelomas, is characterized by the absence of detectable M-protein in… (More)
Is this relevant?
1991
1991
The efficacy of alternating vincristine, melphalan (M), cyclophosphamide, prednisone/vincristine, carmustine, doxorubicin, and… (More)
Is this relevant?
1989
1989
Thirty-three previously untreated patients with multiple myeloma were randomized to either a combination of recombinant… (More)
Is this relevant?
1986
1986
Four hundred forty previously untreated patients with active multiple myeloma were entered into a randomized trial (Southwest… (More)
Is this relevant?